Stimulants

In one analysis, those on a high dose of prescription amphetamines were more than 13 times more likely to develop psychosis/mania.

Lancet Psychiatry, a UK-based medical journal, recently published a study that concluded brain scans showed that individuals diagnosed with ADHD had smaller brains. That conclusion is belied by the study data. The journal needs to retract this study. UPDATE: Lancet Psychiatry (online) has published letters critical of the study, and the authors' response, and a correction.

Service users taking drugs to treat ADHD may be at increased risk for hypertension and arterial disease

Medical researchers present evidence that ADHD is overdiagnosed in children and teens, which can lead to significant harm.

Study examines racial and ethnic disparities in the quality of care for Medicaid-enrolled children starting ADHD medication.

Leading ADHD researchers outline four mistakes that turned ADHD from a description of behavior into a medical disease.

“Efforts to improve learning in children with ADHD should focus on obtaining effective academic instruction rather than stimulant medication.”

A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...

Risk of depression increased when children were taking methylphenidate for ADHD, but once they stopped taking the drug, depression risk dropped to normal levels.

The prescribing of stimulants to preschoolers diagnosed with ADHD is on the rise, which is said to be an "evidence-based" practice. A review of that "evidence base" reveals that claims that ADHD is characterized by genetic and brain abnormalities are belied by the data, and that the NIMH trial of methylphenidate in this age group told of long-term harm.

According to researchers, children are being increasingly prescribed multiple different psychiatric medications.

New data shows that calls to US poison control centers have increased significantly for children taking stimulant ADHD drugs.

A recent Cochrane review has found that serious adverse events occur for about 1% of children and adolescents treated with Ritalin.

The authors of a large scale well-conducted systematic review of methylphenidate, also known as Ritalin, conclude that there is a lack of quality evidence for the drug’s effectiveness. Their research also revealed that Ritalin can cause sleep problems and decreased appetite in children.

Stimulant medications like Ritalin and Adderall, often prescribed to treat children diagnosed with ADHD, are known to cause hallucinations and psychotic symptoms. Until recently these adverse effects were considered to be rare. A new study to be published in the January issue of Pediatrics challenges this belief, however, and finds that many more children may be experiencing psychotic symptoms as a result of these drugs than previously acknowledged.

Hallucinations and other psychotic symptoms have been reported after methylphenidate (Ritalin) treatment for ADHD.

Findings suggest that treatment not only fails to reduce the severity of “ADHD” symptoms in adulthood but is associated with decreased height.

Adults receiving ADHD medications and therapy frequently experience adverse events that interfere with employment and daily life.

This guide to the scientific literature on withdrawal from ADHD drugs provides a review of animal studies, withdrawal syndromes, and possible tapering protocols.

Study of students without an ADHD diagnosis finds that stimulants (Adderall) have little impact on cognitive performance.

The abuse of ADHD drugs on college campuses has reached epidemic proportions, according to the authors of a recent review in the journal of Ethical Human Psychology and Psychiatry. ADHD drugs, like Ritalin and Adderall, have become so commonplace on college campuses that students abusing these drugs for studying, weight loss and partying have underestimated their risks. As a result, we have seen exponential increases in emergency room visits, overdoses, and suicides by students taking these drugs.

A review of "potential neurobiological ramifications of the popular cognitive enhancers," in Frontiers of Systems Neuroscience, finds that stimulants reduce performance at higher dosages, and...

In December, MIA  reported on a systematic Cochrane review on the research for the safety and effectiveness of Ritalin (methylphenidate) that found substantial bias...

Children as young as four in foster care are taking three or more psychotropic medications, and the length of time that children aged six...

A new analysis of FDA data, published on September 10th by the Milwaukee Journal Sentinel/MedPage Today, reveals the dangers of the common prescription of...